According to Arcadia Biosciences's latest financial reports the company's current earnings (TTM) are -$14.38 M. In 2022 the company made an earning of -$18.84 M an increase over its 2021 earnings that were of -$23.04 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$14.38 M | -23.71% |
2022 | -$18.84 M | -18.22% |
2021 | -$23.04 M | 277.41% |
2020 | -$6.11 M | -78.85% |
2019 | -$28.87 M | 524.24% |
2018 | -$4.63 M | -69.04% |
2017 | -$14.94 M | -18.3% |
2016 | -$18.28 M | 19.7% |
2015 | -$15.28 M | -3.03% |
2014 | -$15.75 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Marrone Bio Innovations
MBII | -$16.51 M | 14.86% | ๐บ๐ธ USA |
Codexis
CDXS | -$76.18 M | 429.96% | ๐บ๐ธ USA |
ScottsMiracle-Gro SMG | -$0.48 B | 3,190.89% | ๐บ๐ธ USA |
American Vanguard AVD | $10.29 M | -171.63% | ๐บ๐ธ USA |